WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115447) HUMAN ANTI-CANCER IMMUNOTHERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115447    International Application No.:    PCT/US2005/018395
Publication Date: 08.12.2005 International Filing Date: 25.05.2005
IPC:
A61K 48/00 (2006.01), A61K 39/00 (2006.01), A61K 39/385 (2006.01), C12N 15/63 (2006.01), C12N 15/85 (2006.01), G01N 33/53 (2006.01)
Applicants: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA [US/US]; Center For Technology Transfer, Suite 200, 3160 Chestnut Street, Philadelphia, PA 19104-6283 (US) (For All Designated States Except US).
VONDERHEIDE, Robert, H. [US/US]; (US) (For US Only).
BEATTY, Gregory [US/US]; (US) (For US Only).
COUGHLIN, Christina [US/US]; (US) (For US Only)
Inventors: VONDERHEIDE, Robert, H.; (US).
BEATTY, Gregory; (US).
COUGHLIN, Christina; (US)
Agent: DOYLE, Kathryn; Drinker Biddle & Reath LLP, One Logan Square, 18th and Cherry Streets, Philadelphia, PA 19103 (US)
Priority Data:
60/574,017 25.05.2004 US
Title (EN) HUMAN ANTI-CANCER IMMUNOTHERAPY
(FR) IMMUNOTHERAPIE ANTICANCEREUSE HUMAINE
Abstract: front page image
(EN)The present invention encompasses compositions and methods for activating, stimulating and isolating antigen-specific T cells. The present invention also relates to compositions of antigen-specific T cells and methods of their use in the treatment and prevention of cancer, infectious diseases, autoimmune diseases, immune disfunction related to aging, or any other disease state where antigen-specific T cells are desired for treatment.
(FR)La présente invention concerne des compositions et des méthodes destinées à activer, stimuler et isoler des lymphocytes T spécifiques d'antigène. La présente invention concerne également des compositions à base de lymphocytes T spécifiques d'antigène ainsi que des méthodes pour leur utilisation dans le traitement et la prévention du cancer, des maladies infectieuses, des maladies auto-immunes, du dysfonctionnement immunitaire associé au vieillissement ou de tout autre état pathologique faisant appel aux lymphocytes T spécifiques d'antigène en vue d'un traitement.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)